1. Market Research
  2. > Pharmaceutical
  3. > Drug Delivery Market Trends
Europe Wearable Injectors Market Forecast to Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type ; Application ; End User, and Country

Europe Wearable Injectors Market Forecast to Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type ; Application ; End User, and Country

  • August 2020
  • 117 pages
  • ID: 5974383
  • Format: PDF
  • The Insight Partners
Up to $1000 off Until Nov 30th 2020

Summary

Table of Contents

Search Inside

The Europe wearable injectors market is expected to reach US$ 3586.82 million in 2027 from US$ 1539.88 million in 2019. The market is estimated to grow with a CAGR of 11.3 % from 2020 to 2027.
The growth of the market is driven by the factors such as, increasing chronic diseases prevalence, technological advancements and design development, and conventional drug delivery system limitations. However, the market is likely to have negative impact due to conventional drug delivery system limitations.
Wearable injectors are rapidly gaining their prominence in the market owing to their capabilities in delivering high volume of viscous formulations.The administration of pharmaceuticals via intravenous (IV) infusion is expensive in healthcare settings.

Self-administration of subcutaneous injections is expected to save 30–70% of costs.Moreover, administration through conventional methods poses risks such as inaccurate dosage and needle stick injuries.

The rise in the number of biologic drugs that are not suitable for oral administration has increased the adoption of wearable injection devices.Higher dosage volumes and viscous formulations of these drugs are further emphasizing the need for alternative injection methods such as wearable injectors.

For instance, the enFuse wearable injector manufactured by Enable Injections is used for subcutaneous delivery of high-volume therapeutics outside a healthcare facility. The company has also introduced mobile monitoring and larger volume capabilities to its high-volume wearable injectors.
A new category of wearable products has emerged, bridging the gap between functionality and cost while improving patient safety and quality of life.One such example is Stevanato Group’s cartridge-based wearable device, currently under development, received Best Innovation in Drug Delivery Device award at Pharma pack Awards in 2019.

The product includes a disposable, wearable pod, and reusable handheld controller that serves as the user interface and control unit for the pod.This is used for varied therapeutic areas, including diabetes, hormone therapies, pain management, and Alzheimer’s disease treatment.

Moreover, continuous development by leading players in upgrading the existing wearable injector portfolio is further driving the demand for wearable injectors.For instance, in February 2020, BD, a leading global medical technology company, completed a human clinical trial of the BD Libertas Wearable Injector.

The award-winning injector is currently in development and is designed as a subcutaneous drug delivery system to deliver biologics with viscosities up to 50 cP in 2–5 mL and 5–10 mL configurations.
Thus, technological advancements and design development is the factor contributing to growth of the Europe wearable injectors market in the forecast period.
Europewearable injectors market, based on type, the wearable injectors market is segmented into on-body injectors and off-body injectors.In 2019, the on-body injectors segment held the largest share of the market.

However, off-body injectors segment is expected to grow at the fastest rate during the coming year.
Based on application, the Europewearable injectors market was segmented into oncology, diabetes, autoimmune diseases, cardiovascular disease and other applications.In 2019,oncology segment held the largest share of the market.

Moreover, the autoimmune disease segment is expected to grow at the fastest rate during the coming year.
Based on end user, the Europe wearable injectors market was segmented into homecare settings, hospital and clinical and other end users.In 2019, homecare setting segment held the largest share of the market.

Moreover, the hospitals and clinics segment is expected to grow at the fastest rate during the coming year.

Some of the major primary and secondary sources for the Europewearable injectors market included in the report are, European Council of Medical Research, Ministry of Health and Family Welfare, World Health Organization, European Journal of Cancer (EJC),International Diabetes Federation (IDF), European Society of Cardiology among others.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
20% Off

($3000)

  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Europe Liposome Drug Delivery Market to 2027- Covid-19 Impact and Regional Analysis by Product ; Technology ; Application and Country

  • $ 3000
  • September 2020
  • 124 pages

The Europe liposome drug delivery market was valued at US$ 1,164.54 million in 2019 and is projected to reach US$ 2,160.12 million by 2027; it is expected to grow at a CAGR of 8.2% during the forecast ...

  • Europe
  • Drug Delivery
  • Industry analysis
  • Chronic Disease Prevalence
  • Cancer Incidence

ref:plp2020

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on